About the Authors
- Andrie Koutsoulidou
-
Affiliation Department of Molecular Genetics, Function & Therapy, Cyprus Institute of Neurology & Genetics, P.O. Box 2346, 1683 Nicosia, Cyprus
- Tassos C. Kyriakides
-
Affiliation Yale Center for Analytical Sciences,Yale School of Public Health, 300 George Street, Suite 555, New Haven, CT 06520, United States of America
- George K. Papadimas
-
Affiliation Department of Neurology, Eginitio hospital, Medical School of Athens, 74 Vasilissis Sofias, 11528, Athens, Greece
- Yiolanda Christou
-
Affiliation Neurology Clinic D, Cyprus Institute of Neurology & Genetics, P.O. Box 2346, 1683 Nicosia, Cyprus
- Evangelia Kararizou
-
Affiliation Department of Neurology, Eginitio hospital, Medical School of Athens, 74 Vasilissis Sofias, 11528, Athens, Greece
- Eleni Zamba Papanicolaou
-
Affiliation Neurology Clinic D, Cyprus Institute of Neurology & Genetics, P.O. Box 2346, 1683 Nicosia, Cyprus
- Leonidas A. Phylactou
-
* E-mail: laphylac@cing.ac.cy
Affiliation Department of Molecular Genetics, Function & Therapy, Cyprus Institute of Neurology & Genetics, P.O. Box 2346, 1683 Nicosia, Cyprus
Competing Interests
L.A.P. and A.K. have led a PCT patent application on ‘MiRNA Biomarkers for Myotonic Dystrophy and Methods of Use Thereof’ (PCT/US2013/047934). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: LAP. Performed the experiments: AK. Analyzed the data: AK TCK. Contributed reagents/materials/analysis tools: TCK GKP YC EK EZP. Wrote the paper: AK LAP.